Catheter Precision, Inc.
VTAK · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 6.6% | 48.3% | -4% | – |
| Cost of Goods Sold | $1 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -141.6% | 93.4% | 92.3% | 92.6% |
| R&D Expenses | $0 | $2 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $5 | $4 | $3 |
| Operating Income | -$3 | -$5 | -$4 | -$3 |
| % Margin | -1,336.7% | -2,210.4% | -2,500% | -2,047.7% |
| Other Income/Exp. Net | $1 | -$2 | -$1 | $1 |
| Pre-Tax Income | -$2 | -$6 | -$5 | -$2 |
| Tax Expense | $0 | -$1 | -$1 | $3 |
| Net Income | -$2 | -$5 | -$4 | -$6 |
| % Margin | -996% | -2,574.5% | -2,828.7% | -3,777.2% |
| EPS | -1.7 | -0.38 | -0.36 | -1.35 |
| % Growth | -347.4% | -5.6% | 73.3% | – |
| EPS Diluted | -1.7 | -0.38 | -0.36 | -1.35 |
| Weighted Avg Shares Out | 13 | 13 | 11 | 8 |
| Weighted Avg Shares Out Dil | 13 | 13 | 11 | 8 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$2 | -$6 | -$4 | -$2 |
| % Margin | -732.3% | -2,741.5% | -2,929.4% | -1,278.5% |